Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2020-005215-46Phase 3Completed
Phase 3, randomised trial in acoustic neuroma, facial palsy and sensorineural hearing loss (SNHL) comparing Nimodipine arm with Placebo arm (2 arms). Primary endpoint: Gardner-Robertson Scale. Started Nov 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2020-005215-46.